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The Arf tumor suppressor represents one of several genes encoded at the Cdkn2a and Cdkn2b loci in the
mouse. Beyond its role blunting the growth of incipient cancer cells, the Arf gene also plays an essential
role in development: its gene product, p19Arf, is induced by Tgfβ2 in the developing eye to dampen
proliferative signals from Pdgfrβ, which effect ultimately fosters the vascular remodeling required for
normal vision in the mouse. Mechanisms underlying Arf induction by Tgfβ2 are not fully understood.
Using the chr4Δ70 kb/Δ70 kb mouse, we now show that deletion of the coronary artery disease (CAD) risk
interval lying upstream of the Cdkn2a/b locus represses developmentally-timed induction of Arf resulting
in eye disease mimicking the persistent hyperplastic primary vitreous (PHPV) found in Arf-null mice and
in children. Using mouse embryo ﬁbroblasts, we demonstrate that Arf induction by Tgfβ is blocked in cis
to the 70 kb deletion, but Arf induction by activated RAS and cell culture “shock” is not. Finally, we show
that Arf induction by Tgfβ is derailed by preventing RNA polymerase II recruitment following Smad 2/3
binding to the promoter. These ﬁndings provide the ﬁrst evidence that the CAD risk interval, located at a
distance from Arf, acts as a cis enhancer of Tgfβ2-driven induction of Arf during development.
& 2013 Elsevier Inc. All rights reserved.Introduction
The mouse Cdkn2a and Cdkn2b genetic loci contain three genes
serving as important mammalian tumor suppressors (Fig. 1A).
Cdkn2a includes Ink4a encoding p16Ink4a from three exons, and
this protein inhibits Cyclin-dependent kinases (Cdk) 4 and 6,
thereby activating the Retinoblastoma tumor suppressor (Rb)
and arresting cell proliferation (Serrano et al., 1993). Arf shares
exons 2 and 3 with Ink4a, but its ﬁrst exon (1β) resides approxi-
mately 12 kb upstream of exon 1α of Ink4a, and the protein
encoded by Arf, p19Arf, is translated in an alternate reading frame
(Quelle et al., 1995). Bearing no structural resemblance to p16Ink4a,
p19Arf enhances the functional activity of p53—the other major
mammalian tumor suppressor pathway (Levine, 1989; Levine
et al., 1991). Cdkn2b encodes the p15Ink4b Cdk4/6 inhibitor and
this gene resides 12 kb further upstream of Arf exon 1β (Hannon
and Beach, 1994). This unusual genomic organization in which a
single locus contains three genes regulating the two major
mammalian tumor suppressors is conserved in known mamma-
lian genomes (Gil and Peters, 2006). Gross chromosomal deletionsll rights reserved.
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du (S.X. Skapek).involving Cdkn2a and Cdkn2b or epigenetic silencing of the locus is
relatively common in many human cancers (Baghdassarian and
Ffrench, 1996; Dreyling et al., 1998; Gil and Peters, 2006; Heyman
and Einhorn, 1996; Sharpless and DePinho, 1999). Mouse lines
engineered to lack Arf, Ink4a, or Cdkn2b are susceptible to a wide
range of cancers as they age (Kamijo et al., 1997; Krimpenfort et al.,
2001; Latres et al., 2000; Serrano et al., 1996; Sharpless et al.,
2001).
Some mammalian tumor suppressors also serve pivotal roles in
embryo or cellular development. This is true for Arf, which is
essential for vascular remodeling that accompanies later stages of
eye development (McKeller et al., 2002; Silva et al., 2005). Despite
the aforementioned genomic complexity, we can attribute the
developmental defect to Arf because it is only evident when exon
1β or exon 2 is disrupted, but not in mice lacking exon 1α of the
Ink4a gene (Martin et al., 2004). In this developmental capacity,
p19Arf is expressed between mouse embryonic day (E) 12.5 and
postnatal day (P) 5 to repress Pdgfrβ (Silva et al., 2005; Widau
et al., 2012), a receptor tyrosine kinase required for pericyte
accumulation in the developing mouse (Hoch and Soriano,
2003). Mouse genetic studies demonstrate that deregulated Pdgfrβ
in the Arf−/− embryo drives excess perivascular cell accumulation
around the hyaloid vessels in the developing vitreous space (Silva
et al., 2005; Widau et al., 2012). The hyaloid vessels normally
involute between P5 and P10 in the mouse and in late stages of
Fig. 1. PHPV-like eye phenotype in chr4Δ70 kb/Δ70 kb mice. (A) Schematic diagram showing Cdkn2a and Cdkn2b genetic loci, which encodes p16Ink4a, p19Arf and p15Ink4b.
A long non-coding RNA (lncRNA), AK14831 (putative mouse “Anril”), is transcribed starting proximal to and proceeding upstream of Cdkn2a. A putative enhancer element (E?)
may lie within the deleted 70 kb segment orthologous to human chromosome 9p21 (see Discussion). (B) Representative photomicrographs of hematoxylin- and eosin-
stained slides of E13.5 embryos, P2 and 9 months showing the primary vitreous hyperplasia in chr4Δ70 kb/Δ70 kb mice (b, d, f) but not in its wild type littermates (a, c, e). Inset
(a and b) shows higher magniﬁcation of vitreous area. Arrows (c and d) show hyperplastic retrolental mass in mutant eye. Asterisk (f) shows pigmented cells in retrolental
mass. Photos were taken at 20 . (C) Representative photomicrographs of immunoﬂuorescence-stained slides of E13.5 embryos showing TO-PRO-3 (a, b), phospho-histone
H3 (c, d) and the overlay (e, f) of primary vitreous hyperplasia in chr4Δ70 kb/Δ70 kb embryos (b, d, f) and wild type littermates (a, c, e). Photos were taken at 40 magniﬁcation.
(g) Quantiﬁcation of the phospho-histone H3 stained cells, presented as % total cells in vitreous of E13.5 embryos, showed two-fold increase of phospho-histone H3 staining
from chr4Δ70 kb/Δ70 kb embryos versus those fromwild type littermates. L, lens. R, retina. Arrowhead, vitreous. (D) Representative agarose gel showing the genotyping of wild
type, chr4Δ70 kb/Δ70 kb, and Arf+/lacZ mice.
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when embraced by overgrowing perivascular cells (Silva et al.,
2005). Hyperplasia in the primary vitreous and persistence of the
hyaloid vessels leads to secondary pathological changes in the lens
and retina, mimicking a human eye disease known as Persistent
Hyperplastic Primary Vitreous (PHPV) (Haddad et al., 1978;
Shastry, 2009) or Persistent Fetal Vasculature (PFV) (Goldberg,
1997), and rendering Arf−/− animals sightless (Martin et al., 2004).
Of note, PFV was suggested as a more unifying term to account
for the fact that what had historically been called PHPV can have a
broad range of manifestations from relatively small remnants of the
hyaloid vessels in the anterior or posterior vitreous space to truly
hyperplastic lesions (Goldberg, 1997). This disease spectrum is also
reﬂected in mouse models in which the primary defect seems to be
in pro-apoptotic events needed to eliminate hyaloid vessel endothe-
lial cells, such as BALB/cOlaHsd mice lacking p53 (Reichel et al.,
1998), mice lacking Ang2 (Hackett et al., 2002), or mice with
defective hyalocyte-mediated signaling from Wnt7b to FZD4 and
Lrp5 (Kato et al., 2002; Lang and Bishop, 1993; Lobov et al., 2005).
These models truly reﬂect persistence of fetal vasculature (PFV). In
contrast, primary vitreous hyperplasia is the major defect in animals
with deregulated expression of Vegf-A (Rutland et al., 2007) or the
immediate early protein IE180 of Pseudorabies Virus (Taharaguchi
et al., 2005), or in the absence of Tgfβ2 (Freeman-Anderson et al.,
2009) (discussed more below). The Arf−/− phenotype described
above also principally represents primary vitreous hyperplasia,
hence our reference to the disease as PHPV.
With an essential role for Arf in development and the general
importance of the Cdkn2a/b locus in cancer biology, understanding
how its expression is controlled represents a fundamental ques-
tion. Several points are already clear. First, the entire locus can beregulated as a single unit by epigenetic silencing by Polycomb
repressor complexes (Gil and Peters, 2006). Certain transcriptional
repressors, such as Bmi1 (Jacobs et al., 1999) and Cbx7 (Gil et al.,
2004), work to silence Cdkn2a/b expression throughout much of
the developing embryo, and perhaps as a mechanism to evade
their tumor suppressive effects. Second, Arf is induced by a variety
of oncogenic stimuli such as expression of activated forms of
RAS (Lin and Lowe, 2001; Palmero et al., 1998), Adenovirus E1a
(de Stanchina et al., 1998), and Myc (Zindy et al., 1998), and supra-
physiologic mitogenic signals from cell culture “shock” (Sherr and
DePinho, 2000; Zindy et al., 1998). Of course, these general
mechanisms cannot account for the tightly controlled expression
of Arf in the developing eye. In the normal developmental context,
Tgfβ2 is required for Arf expression in the hyaloid vasculature, and
also in the internal umbilical vessels; Tgfβ2 deﬁcient mice develop
PHPV like Arf−/− mice (Freeman-Anderson et al., 2009). Tgfβ2
signals through TβrII to activate Smads 2 and 3 and p38 Mapk,
which are essential for Arf induction (Zheng et al., 2010); in mouse
embryo ﬁbroblasts (MEFs), these effects are limited to Arf, not
the entire Cdkn2a/b locus—implying a regulatory mechanism in
normal development that is distinct from its control in response to
pathological states such as oncogenic stress.
We have focused on understanding the molecular mechanisms
that drive Tgfβ-dependent control of Arf during eye development.
We are considering the general hypothesis that additional cis-acting
elements are needed to explain the temporal response to Tgfβ
(i.e., delayed transcriptional induction despite immediate Smad 2/3
binding to the Arf promoter) and the temporally- and spatially-
restricted expression pattern of Arf despite wide spread effects of
Tgfβ. We became interested in a 70 kb segment of genomic DNA
lying about 100 kb upstream of the Cdkn2b/Cdkn2a locus (Fig. 1A).
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teny with a 58 kb intragenic region that is strongly linked to
coronary artery disease (CAD) risk in humans (Helgadottir et al.,
2007; McPherson et al., 2007). Single nucleotide polymorphisms in
the so-called CAD risk allele at human chromosome 9p21, and
knockout of the orthologous 70 kb region in the mouse genome,
can inﬂuence the expression of ﬂanking Cdkn2a and Cdkn2b genes
(Liu et al., 2009; Visel et al., 2010). Here we report that this genomic
locus contains a cis-acting element that is required for Tgfβ2-driven
Arf expression and proper eye development, and we provide
mechanistic insight into how it operates in a manner that is distinct
from oncogene-driven Arf induction.Materials and methods
Animals and cell culture
Chr4Δ70 kb/Δ70 kb mice (Visel et al., 2010) were obtained from
NCI Mouse Models of Human Cancer Consortium repository.
ArflacZ/+ mice generated in the Skapek laboratory (Freeman-
Anderson et al., 2009) were maintained in a mixed C57BL/
6129/Sv genetic background. The University of Texas South-
western Medical Center Animal Care and Use Committee approved
all laboratory animal studies.
Primary MEFs from wild type, ArflacZ/+, chr4Δ70 kb/Δ70 kb,
chr4Δ70 kb/+, and ArflacZ/+, chr4+/Δ70 kb mice were derived and
cultivated by us as previously described (Zindy et al., 1997). Tgfβ1
was obtained from R&D Systems, Inc. (Minneapolis, MN). Of note,
Tgfβ1 was used throughout as we previously established that
Tgfβ1, 2, and 3 have similar effects on Arf expression (Zheng
et al., 2010). β-galactosidase activity was measured in cultured
cells using a commercial kit (Applied Biosystems; Foster City, CA).
MSCV-based retrovirus vector encoding human H-RASV12 and GFP,
or just GFP, was produced in our laboratory using vectors from
Addgene (Cambridge, MA). Antibodies used in Western blotting
experiments were directed against Hsc70 (Santa Cruz Biotechnol-
ogy, Inc.; Santa Cruz, CA) and p19Arf (Abcam Inc.; Cambridge, MA).
Histology studies
Mouse embryos were obtained at E13.5 from females euthanized
by CO2 and processed for parafﬁn or cryostat sectioning and routine
staining as described previously (Martin et al., 2004; McKeller et al.,
2002). Phospho-histone H3 immunoﬂuorescence staining was used
to assess proliferation using 8 μm cryostat sections as follows:
sections were incubated in 96 1C citrate buffer (pH 6) for 30 min
for antigen retrieval, blocked in 10% goat serum with 0.1% Triton
X-100 in PBS, and stained using rabbit anti-phospho-histone H3
(ser 10) antibody (1:500, Millipore; Temecula, CA) followed by Cy3-
conjugated goat anti-rabbit antibody (1:250, Jackson ImmunoRe-
search Laboratories, Inc., West Grove, PA) and counterstaining with
TO-PRO-3 (Life Technologies). The fraction of positively stained cells
was determined using paired littermates from 5 litters and veriﬁed
by two individuals who were blinded to the genotypes. Pdgfrβ was
detected using goat anti-Pdgfrβ (AF1042, R&D Systems) as pre-
viously described (Silva et al., 2005). All immunoﬂuorescence
staining was visualized using a Zeiss 510 NLO multi-photon/con-
focal laser-scanning microscope at 20 or 40 magniﬁcation.
Laser-capture microdissection (LCM)
LCM was accomplished as previously described (Widau et al.,
2012). Brieﬂy, mouse embryos were harvested at E13.5 for LCM.
Embryo heads were immediately embedded in OCT freezing
medium without ﬁxation. 14 μm sections were cut on a CryoStarNX70 cryostat, mounted on PEN Membrane Metal Slides (Applied
Biosystems), and stained with hematoxylin and eosin (Molecular
Machines & Industries AG; Glattbrugg, Switzerland). LCM was
carried out with the Arcturus Veritas Microdissection System. At
least 10, micro-dissected sections from the vitreous, lens, and
retina were pooled from each embryo. Total RNA was extracted
using the Arcturus PicoPure LCM RNA isolation kit (Applied
Biosystems) and the expression of speciﬁc genes was analyzed
with real time RT-PCR as described below.
RT-PCR
Total RNAwas extracted from cell pellets or LCM tissue dissolved in
Trizol (Invitrogen), according to the manufacturer's recommendations.
Total RNA (2 μg) was used to synthesize cDNA with Superscript III RT
kits (Invitrogen) and quantitative RT-PCR (qRT-PCR) was performed
using Fast SYBR Green Master mix and a model 7900HT Fast Cycler
instrument (both from Applied Biosystems). The primers were as
follows: Arf: 5′-TTCTTGGTGAAGTTCGTGCGATCC (forward) and 5′-
CGTGAACGTTGCCCATCAT CATCA (reverse); Pdgfrβ: 5′-AACAGAAGA-
CAGGGAGGTGG-3′ (forward) and 5′-TGGTATCACTCCTGGAAGCC-3′
(reverse); p21Cip1: 5′-CAGATCCACAGCGATATCCA (forward) and 5′-
ACGGGACCGAAGAGACAAC (reverse); p15Ink4b: 5′-GATCCCAACGCCCT-
GAAC (forward) and 5′-TGGTAAGGGTGGCAGGGT (reverse); Pai-1: 5′-
GCCTCCTCATCCTGCCTAA (forward) and 5′-TGCTCTTGGTCGGAAA-
GACT- (reverse); Gapdh: 5′-TCAACAGCAACTCCCACTCTTCCA (forward)
and 5′-ACCCTGTTGCTGTAGCCGTATTCA (reverse). Results are pooled
from three separate experiments.
Chromatin immunoprecipitation (ChIP)
ChIP was performed as previously described (Zheng et al., 2010).
Brieﬂy, MEFs (5106/ChIP) were treated with Tgfβ1 (5 ng/ml) or
vehicle 24 h. Cells were cross-linked, sonicated, and subjected to
immunoprecipitation using anti-Smad2/3 antibody (sc6033, Santa
Cruz Biotechnology), or anti-RNA polymerase II (sc899, Santa Cruz).
Rabbit IgG (sc2027, Santa Cruz) or goat IgG (AB-108-C, R&D
Systems) was used as a negative control. Protein A/G sepharose
beads (sc2003, Santa Cruz) were used to collect the protein–
chromatin complexes. The beads were washed sequentially with
low salt, high salt, LiCl and TE buffers (Upstate ChIP Kit, Millipore)
and eluted in 0.1 M NaHCO3, 1% SDS. Cross-linking was reversed by
incubation at 67 1C overnight and the genomic DNA was extracted
using Qiagen PCR Puriﬁcation Kit. Quantitative analysis of the
precipitated and input DNA was carried out using speciﬁc primer
sets and Fast SYBR green master mix on a model 7900HT Fast Cycler
instrument (both from Applied Biosystems). The primer sets for Arf
promoter regions were as follows: 5′-AGATGGGCGTGGAGCAAAGAT
(forward) and 5′-ACTGTGACAAGCGAGGTGAGAA (reverse).
Statistical analysis
Quantitative data are presented as the mean+S.D. from three or
more representative experiments. Statistical signiﬁcance (p value
o0.05) was calculated using Student's t test.Results
PHPV-like eye phenotype in the chr4Δ70 kb/Δ70 kb mouse
We evaluated the developmental importance of the 70 kb
interval lying upstream of Cdkn2b/Cdkn2a (Fig. 1A), which is
orthologous to the human chromosome 9p21 CAD risk interval
(Visel et al., 2010), by examining eyes taken from chr4Δ70 kb/Δ70 kb
and wild type mice at embryonic and postnatal points. Deleting
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E13.5 (Fig. 1B, b versus a); a retrolental ﬁbrovascular mass in the
immediate postnatal period (Fig. 1B, d versus c); and progressive
accumulation of pigmented cells within this mass as animals aged
(Fig. 1B, f versus e). These pathologic features, perfectly mimickingFig. 2. Loss of the 70 kb CAD risk interval decreases Arf mRNA but increases Pdgfrβ expr
(R) from E13.5 WT mouse embryos. qRT-PCR analysis of (B) Arf and (C) Pdgfrβ were c
embryos and wild type littermate embryos. Expression was normalized to that of G
n(increase), po0.05. (D) Representative photomicrographs of immunoﬂuorescence-sta
overlay (c, f) of primary vitreous hyperplasia in chr4Δ70 kb/Δ70 kb embryos (d, e, f) and wild
(b, e) depicts such staining in choroid/sclera.the PHPV-like phenotype in Arf−/− mice (McKeller et al., 2002),
were observed in all chr4Δ70 kb/Δ70 kb we examined (n46), and
none of the heterozygous (n43) or wild type littermates (n46).
Of note, the progressive accumulation of pigmented cells within
the retrolental mass has occasionally been observed in humanession in vitreous of developing eye. (A) LCM of the vitreous (V), lens (L) and retina
arried out using total RNA isolated from the vitreous from E13.5 chr4Δ70 kb/Δ70 kb
apdh. The results were average of three independent experiments. #(decrease),
ined sections from E13.5 embryos showing TO-PRO-3 (a, d), Pdgfrβ (b, e) and the
type littermates (a, b, c). Arrow (b, e) depicts Pdgfrβ staining in vitreous; arrowhead
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eyes, which are also severely affected (Martin et al., 2004). In that
model, their progressive accumulation with time, occasional
absence even in severely affected eyes, and anatomic evidence
suggesting their migration from the hyaloid artery stalk, all
suggested to us that the cells might represent retinal pigment
epithelial cells reacting as a secondary event to the severe
vitreoretinopathy (Martin et al., 2004).
The primary vitreous hyperplasia in Arf−/− animals (McKeller
et al., 2002), and in Tgfβ2−/− mice where Arf mRNA is diminished
(Freeman-Anderson et al., 2009), is primarily driven by excess
proliferation evident as early as E13.5. Immunostaining for
phospho-histone H3 demonstrated an approximately two-fold
increase in the relative number of cells proliferating in the vitreous
of chr4Δ70 kb/Δ70 kb mice eyes as compared to wild type controls
(Fig. 1C). Because the morphological changes and this functional
assay mirrored the Arf−/− phenotype, we used PCR to conﬁrm that
the Arf exon 1β was not inadvertently deleted in the chr4Δ70 kb/
Δ70 kbanimals (Fig. 1D). Taken together, these results indicate that
loss of the CAD risk allele in the chr4Δ70 kb/Δ70 kb mouse blocks
normal eye development leading to a PHPV-like eye disease.
Failed Arf induction and Pdgfrβ repression in chr4Δ70 kb/Δ70 kb mouse
Given the fact that the Arf deﬁcient developmental defect
occurs in chr4Δ70 kb/Δ70 kb mouse, we examined whether ArfFig. 3. Tgfβ fails to activate Arf, Ink4b and Cdkn1a (Cip1). Quantitative analysis of Arf (A),
Δ70 kb and wild type MEFs exposed to vehicle (V) or Tgfβ (Τ) for 48 h. Differences in transc
(n)]. (E, F) Quantitative analysis of representative chromatin immunoprecipitation (ChIP)
(T) for 24 h. ChIP assay was carried out using antibodies speciﬁc to (E) Smad2/3,
Immunoprecipitated and input DNA were ampliﬁed with primers speciﬁc for the proximexpression was inﬂuenced as the primary vitreous develops.
To accomplish this, we utilized laser-capture microdissection
(LCM) to speciﬁcally assess Arf expression in the lens, the retina,
and the vitreous space at E13.5 (Fig. 2A). This approach conﬁrmed
that Arf expression was limited to the vitreous, as we previously
established (Silva et al., 2005) (YZ and SXS, additional data not
shown), and that its expression was dramatically diminished in
chr4Δ70 kb/Δ70 kb embryo eyes (Fig. 2B). p19Arf controls Pdgfrβ
mRNA and protein expression in both p53-dependent and inde-
pendent mechanisms, respectively (Silva et al., 2005; Widau et al.,
2012), and deregulated Pdgfrβ is required for the primary vitreous
hyperplasia in Arf−/− mice (Silva et al., 2005). Consistent with
diminished Arf representing the key defect in chr4Δ70 kb/Δ70 kb
embryos, Pdgfrβ mRNA and protein were both increased in the
vitreous of the mutant mice as compared to wild type littermates
(Fig. 2C and D, e versus b). Finding similar Pdgfrβ immunostaining
in the choroid/sclera (Fig. 2D, arrowhead) demonstrated that the
increased expression of this receptor was not a global change but
was limited to the anatomic sites where p19Arf normally resides.
We previously established that Tgfβ2 is an essential regulator of
Arf in the developing eye and Tgfβ1, 2, and 3 can each induce p19Arf in
cultured MEFs and in HeLa cells (Freeman-Anderson et al., 2009;
Zheng et al., 2010) (additional data not shown). As expected, mice
lacking Tgfβ2 develop primary vitreous hyperplasia that resembles
the Arf−/− eye disease (Freeman-Anderson et al., 2009). The fact that
Arf mRNA is low in chr4Δ70 kb/Δ70 kb mice suggested that the normalInk4b (B), Cip1 (C) and Pai-1 (D) by RT-PCR using total RNA isolated from chr4Δ70 kb/
ript level between Tgfβ- and vehicle-treated wild type MEFs are signiﬁcant [po0.05
assays of using chr4Δ70 kb/Δ70 kb and wild type MEFs exposed to vehicle (V) or Tgfβ
(F) RPol II expressed relative to IgG and normalized against vehicle control.
al Arf promoter. npo0.05 for Tgfβ versus corresponding vehicle.
Y. Zheng et al. / Developmental Biology 380 (2013) 49–5754Tgfβ2-driven induction of this transcript might be blocked by
deletion of the CAD risk interval. We investigated this concept
further using cultured MEFs. First, quantitative RT-PCR found basal
Arf expression in chr4Δ70 kb/Δ70 kb MEFs to be much lower than in
similarly passed wild type MEFs (Fig. 3A), consistent with a previous
report (Visel et al., 2010) and our in vivo studies (Fig. 2B). Tgfβ1
increased Arf mRNA and p19Arf protein expression in wild type MEFs
but failed to do so in chr4Δ70 kb/Δ70 kb MEFs (Fig. 3A; and additional
data not shown). Similar ﬁndings were observed for Cdkn2b and
Cdkn1a mRNA, encoding p15Ink4b and p21Cip1, respectively (Fig. 3B
and C). We recognize that failed Cdkn1a induction might be
secondary to failed p19Arf-dependent activation of p53. Moreover,
Tgfβ still augmented the expression of plasminogen activator
inhibitor-1 (PAI-1) in these MEFs, even though the basal levels for
this transcript were lower than in the wild type cells (Fig. 3D).
In response to Tgfβ signaling, Smads 2/3 bind to the Arf promoter
and they are required for Tgfβ induction of p19Arf (Zheng et al.,
2010). Indeed, Smads 2/3 were recruited to the Arf promoter
following Tgfβ stimulation in chr4Δ70 kb/Δ70 kb MEFs at least as well
as in wild type cells (Fig. 3E). Following Smad 2/3 binding, delayed
recruitment of RNA polymerase II (RPol II) to the Arf promoter
coincides with increased Arf mRNA (Zheng et al., 2010). Even
though Smad 2/3 binding to the promoter was enhanced, RPol II
was not recruited in chr4Δ70 kb/Δ70 kb MEFs (Fig. 3F). Of note, the
lower basal Arf expression in the chr4Δ70 kb/Δ70 kb could not be
attributed to differences in Smad 2/3 and RPolII binding, both of
which were low in the vehicle treated MEFs regardless of genotype
(YZ and SXS, negative data not shown).Fig. 4. Cis elements in the 70 kb CAD interval are required for Arf induction by Tgfβ but n
β-galactosidase and Arf mRNA, respectively, in ArflacZ/+, chr4+/Δ70 kb MEFs treated with
chr4+/Δ70 kb and Arf+/+, chr4+/Δ70 kb MEFs. mRNA expression, normalized to Gapdh, expres
from human H-RASV12 induce p19Arf in chr4Δ70 kb/Δ70 kb MEFs. Representative western bl
after transduction with Gfp- or H-RASV12-expressing retrovirus. (E) qRT-PCR analysis of
nnpo0.05 for P7 versus P2 in chr4Δ70 kb/Δ70 kb and wild type, respectively. (F) Cell count
cultured for 6 days. n, and nnpo0.05 for chr4Δ70 kb/Δ70 kb versus wild type for P2 and P9The 9p21 CAD risk interval contains a cis-acting enhancer that
cooperates with Tgfβ, but not oncogenic RAS, to induce Arf
transcription
Deletion of the CAD risk allele in the mouse represses Cdkn2b
in cis in the heart and several other organs (Visel et al., 2010). To
test whether Arf induction by Tgfβ was similarly affected, we
derived MEFs from ArflacZ/+, chr4+/Δ70 kb mouse embryos. In these
cells, native Arf lies in cis to the 70 kb deletion whereas the lacZ
cDNA driven by the Arf promoter resides on a chromosome
retaining the putative upstream regulatory elements (Fig. 4A).
Exposure of the MEFs to Tgfβ1 induced β-galactosidase activity but
not the endogenous Arf mRNA in ArflacZ/+, chr4+/Δ70 kb MEFs,
whereas the native Arf mRNA was induced in the Arf+/+, chr4+/Δ70 kb
MEFs (Fig. 4B and C). Of note, some evidence from human cells
supports the concept that ANRIL, a long non-coding RNA extending
into the CAD risk allele, serves to recruit Polycomb repressor
complexes in cis to Cdkn2a and Cdkn2b promoters (Kotake et al.,
2011; Yap et al., 2010). Tgfβ exposure did not measurably change the
expression of AK148321, the mouse ANRIL ortholog (YZ and SXS,
negative data not shown).
Ectopic expression of human H-RASV12 and serial passage in
culture also induce Arf transcription in MEFs and murine kerati-
nocytes (Lin and Lowe, 2001; Palmero et al., 1998; Zindy et al.,
1998). Because it is not yet clear whether mechanisms underlying
Arf induction by Tgfβ are also utilized in these scenarios, we
investigated the role that this intergenic region plays in Arf
induction by other stimuli. As expected, mutant RAS inducedot other stimuli. (A) Schematic diagram showing potential cis and trans activation of
Tgfβ. β-galactosidase activity (B) and qRT-PCR analysis of Arf mRNA (C) in ArflacZ/+,
sed relative to that in vehicle treated ArflacZ/+, chr4+/Δ70kb MEFs. (D) Oncogenic signal
ot for the indicated proteins using lysates from chr4Δ70 kb/Δ70 kb and wild type MEFs
Arf mRNA using chr4Δ70 kb/Δ70 kb and wild type MEFs from different passage. n and
ing assay of chr4Δ70 kb/Δ70 kb and wild type MEFs from different passage after being
, respectively.
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in chr4Δ70 kb/Δ70 kb MEFs, although the basal expression was lower
(Fig. 4D). Similarly, Arf mRNA and p19Arf protein were induced by
serial passage of both wild type and chr4Δ70 kb/Δ70 kb MEFs (Fig. 4E;
additional data not shown). Of note, Arf induction may be relevant
to diminished cell accumulation that we observed in early versus
later passage wild type or chr4Δ70 kb/Δ70 kb MEFs (Fig. 4F); however,
the much greater accumulation of chr4Δ70 kb/Δ70 kb MEFs, indepen-
dently of cell passage number, strongly implies that differential
induction of other cell cycle regulators such as p16Ink4a or p15Ink4b
also contributes to differential proliferation in these cells. Viewed
together, the simplest interpretation of our ﬁndings is that a cis-
acting element resides within the deleted CAD risk interval and it
is required for Arf promoter activation in MEFs by Tgfβ but not by
oncogenic RAS or cell culture “shock”.Discussion
Several recent genome-wide association studies (GWAS) have
linked common sequence variants in a 58 kb gene-poor region of
human chromosome 9p21 to coronary artery disease and type
2 diabetes (Helgadottir et al., 2007; McPherson et al., 2007; Saxena
et al., 2007; Scott et al., 2007; Zeggini et al., 2007). Due to the
importance of this so-called coronary artery disease (CAD) risk
allele, the orthologous region was deleted to generate the
chr4Δ70 kb/Δ70 kb mouse (Visel et al., 2010). Although the mutant
mice seem to suffer slightly increased embryonic and neonatal
lethality, they were thought to be overtly normal at birth. More
importantly, they displayed increased weight gain and mortality,
especially when fed high-fat, high-cholesterol diets (Visel et al., 2010).
Increased tumor susceptibility was noted in the chr4Δ70 kb/Δ70 kb
animals, but how this related to the increased mortality with a
“western” diet and the physiological derangements underlying the
increased weight gain was not clear. Indeed, the only molecular
changes in the animal related to decreased Cdkn2a and Cdkn2b in the
heart and several other organs. Again, how these molecular defects
translated to disease was not established.
We now provide deﬁnitive evidence for a developmental defect
in these animals, and we demonstrate a molecular mechanism
that can account for the disease: chr4Δ70 kb/Δ70 kb mice suffer a
developmental defect in the eye that perfectly mimics that
observed in the absence of the Arf tumor suppressor in a model
for severe PHPV (McKeller et al., 2002). Arf expression in the
primary vitreous at E13.5 – the critical initial phase of primary
vitreous development – is extremely low in chr4Δ70 kb/Δ70 kb mice
and, consequently, Pdgfrβ is elevated to drive the proliferation of
pericyte-like cells, which is fundamental to the PHPV in the Arf−/−
model (Silva et al., 2005; Widau et al., 2012). We previously
established that Tgfβ2 is the dominant signal that controls Arf
expression in the eye (Freeman-Anderson et al., 2009; Zheng et al.,
2010). Although Tgfβ can still activate Smad proteins and enhance
the expression of at least one target gene, it fails to increase Arf
transcription in chr4Δ70 kb/Δ70 kb MEFs because RPolII is not
recruited to the promoter. In summary, our ﬁndings provide the
ﬁrst mechanistic link between molecular derangements due to
deletion of the CAD risk allele and disease in the mouse.
Two important caveats should be emphasized. First, our
mechanistic studies were carried out in MEFs, whereas Arf is
expressed in a limited number of perivascular cells ﬂanking the
hyaloid and internal umbilical vessels and their relationship to
MEFs is not clear (Freeman-Anderson et al., 2009; Martin et al.,
2004). We know the Arf expressing cells in the eye are derived
from a Wnt1-expressing lineage because targeted inactivation of
Arf in that lineage recapitulates the Arf−/− eye phenotype (Zheng
et al., 2010). In vivo, the cells express NG-2, Pdgfrβ, and smoothmuscle α-actin to some extent (Martin et al., 2004; Silva et al.,
2005; Thornton et al., 2007), all of which can be expressed in
pericytes; indeed, this swayed us to refer to them as “pericytes” in
a recent manuscript (Widau et al., 2012). But it is important to
emphasize that true pericytes are deﬁned by their anatomic
location within the vascular basement membrane and their
intimate, “peg and socket” interactions with endothelial cells
(Armulik et al., 2005; Hirschi and D'Amore, 1996), and we have
not carried out the studies needed to precisely deﬁne the Arf
expressing cells as pericytes.
Regardless of whether the Arf expressing cells represent true
pericytes, features of our MEFs model do reﬂect the in vivo biology,
though, such as their expression of Pdgfrβ and its repression by
p19Arf (Silva et al., 2005; Widau et al., 2012), Tgfβ2 induction of Arf
(Freeman-Anderson et al., 2009; Zheng et al., 2010), and dimin-
ished Arf mRNA in chr4Δ70 kb/Δ70 kb cells shown here. Ideally, we
would study the very cells that express Arf in vivo. Our preliminary
ﬁndings indicate that we can use FACS to sort the Gfp-expressing
cells from the postnatal eye in Arf Gfp/Gfp animals, and we are
striving to derive them from Arf Gfp/+, chr4+/Δ70 kb animals
(mimicking experiments shown in Fig. 4A and C). But even this
system may suffer from two potential pitfalls. Tgfβ2 has already
activated the Arf promoter in the cells we purify, and this may cast
doubt on mechanistic studies focused on the initial Arf induction.
More importantly for this work, even if we can derive Arf Gfp/Gfp,
chr4Δ70 kb/Δ70 kb animals by careful screening for homologous
recombination placing the two mutant alleles in cis, we may not
be able to use FACS to isolate them because the Gfp reporter will
not likely be expressed.
Second, our studies have focused on the hyperplasia in the
primary vitreous. As discussed above, PHPV/PFV represents a
spectrum of diseases that affect different aspects of the hyaloid
vasculature, from the hyaloid artery and vasa hyaloidea propria in
the vitreous to the tunica vasculosa lentis (TVL) embracing the
lens and the pupillary membrane (PM) (Goldberg, 1997). We
previously demonstrated that the TVL and PM regress normally
in the absence of Arf (Martin et al., 2004), which ﬁnding is
consistent with the fact that Arf expressing perivascular cells are
not found in the more anterior elements of the hyaloid vasculature
(Freeman-Anderson et al., 2009; Martin et al., 2004; McKeller
et al., 2002). Based on the fact that Arf expression is dampened in
the vitreous of chr4Δ70 kb/Δ70 kb mouse embryo, we assume that
the regression of anterior elements of the hyaloid vessels will not
be affected by deletion of the CAD risk interval. This is supported
by our analysis of several mature chr4Δ70 kb/Δ70 kb animals (CCD, YZ
and SXS, unpublished data), but we cannot exclude a more subtle
delay that is unrelated to the regulation of Arf.
Others have previously linked alterations in the expression of
genes in the Cdkn2a/b locus to polymorphisms in the CAD risk
interval (Liu et al., 2009) and, as mentioned above, in the mouse
model (Visel et al., 2010). Mechanisms to account for how this
region inﬂuences gene expression at a distance are still being
unraveled. This genomic segment includes exons in a long non-
coding RNA (lncRNA), ANRIL, the transcription of which actually
starts just proximal to and proceeding upstream of Cdkn2a
(Fig. 1A) (Pasmant et al., 2007). In cultured human cells, the ANRIL
transcript interacts with CBX7 and SUZ12, key components of
Polycomb repressor complexes PRC1 and 2, respectively, and
recruits them to silence the entire CDKN2b/CDKN2a locus
(Kotake et al., 2011; Yap et al., 2010). It is assumed that speciﬁc
polymorphisms correlating with changes in Cdkn2a/b gene expres-
sion may inﬂuence the known differential splicing of ANRIL and
this somehow inﬂuences promoter activation.
This proposed model is somewhat difﬁcult to reconcile with
ﬁndings in the mouse. The region deleted in the chr4Δ70 kb/Δ70 kb
mouse includes several exons in the putative mouse “Anril”
Y. Zheng et al. / Developmental Biology 380 (2013) 49–5756(formally: AK148321). We did not detect Tgfβ-driven changes in
mouse AK148321 expression in MEFs—which might be expected if
it were forming a cis-repressor complex like human ANRIL. Nor did
we observe signiﬁcantly different expression of AK148321 in wild
type versus chr4Δ70 kb/Δ70 kb mice (YZ and SXS, negative data not
shown). While it is formally possible that deletion of the CAD risk
allele in the mouse may facilitate transcriptional silencing from a
mutated form of this lncRNA, we favor an alternative hypothesis
that this segment contains a previously unrecognized cis-activat-
ing element, as proposed by the Pennacchio laboratory (Visel et al.,
2010). Interestingly, their search for such elements is reported
to have been limited to E11.5 mouse embryos, which is two
days before robust Arf promoter activity is evident in the embryo
(Silva et al., 2005). Further, our ﬁnding that the CAD risk element is
required for Tgfβ-driven activation of Arf but not for induction
by other stimuli also speaks to speciﬁc interactions that such a
cis-enhancer may make with Smad 2/3 binding elements at this
promoter.
Finally, our results might help to explain the other pathological
ﬁndings in the chr4Δ70 kb/Δ70 kb. Obviously, the enhanced tumor
susceptibility might merely be due to decreased expression of Arf
and other genes at this locus. However, the fact that an oncogenic
form of RAS can enhance Arf expression in MEFs does cast some
doubt on this potential explanation. As mentioned above, a
comprehensive search for metabolic or pathological changes,
including atherogenic plaques, in the original description of the
mouse did not unveil a precise cause for enhanced coronary artery
disease risk either. Our developmental studies of the mouse eye
implicate p19Arf as an essential regulator of perivascular cell
proliferation and Pdgfrβ expression in the primary vitreous (Silva
et al., 2005; Widau et al., 2012). One might consider whether such
failed induction of Arf in perivascular cells in other vessels might
contribute to the disease. It is important to emphasize that we
have only found Arf expressing perivascular cells within the
hyaloid and internal umbilical vessels in the embryo and early
postnatal period; however, we have also not studied this exten-
sively in older animals, nor in animals stressed by a high-fat and
high-cholesterol diet.Conclusions
Our studies demonstrated that the CAD risk interval acts as a cis
enhancer of Tgfβ2-driven induction of Arf during development.
Loss of the CAD risk interval represses the developmentally timed
induction of Arf, resulting in eye disease resembling PHPV found in
Arf-deﬁcient mice.Acknowledgment
We gratefully acknowledge A. Visel and L.A. Pennacchio (Lawrence
Berkeley National Laboratory) for sharing mouse tissue specimens
from chr4Δ70 kb/Δ70 kb animals for an initial analysis; C.J. Sherr
(St. Jude Children's Research Hospital) for helpful initial discussions;
K. Bachmeyer and L. Roach (both at the University of Chicago) for
technical assistance; and Syann Lee and Joel Elmquist (both at UT
Southwestern Medical Center) for assistance with laser capture
microdissection. This research is supported by grants to SXS from
the National Eye Institute (EY 014368 and EY 019942).
References
Armulik, A., Abramsson, A., Betsholtz, C., 2005. Endothelial/pericyte interactions.
Circ. Res. 97, 512–523.
Baghdassarian, N., Ffrench, M., 1996. Cyclin-dependent kinase inhibitors (CKIs) and
hematological malignancies. Hematol. Cell Ther. 38, 313–323.Dreyling, M.H., Roulston, D., Bohlander, S.K., Vardiman, J., Olopade, O.I., 1998.
Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma
may be associated with histologic transformation from low-grade to diffuse
large-cell lymphoma. Genes Chromosomes Cancer 22, 72–78.
Freeman-Anderson, N.E., Zheng, Y., McCalla-Martin, A.C., Treanor, L.M., Zhao, Y.D.,
Garﬁn, P.M., He, T.C., Mary, M.N., Thornton, J.D., Anderson, C., Gibbons, M., Saab,
R., Baumer, S.H., Cunningham, J.M., Skapek, S.X., 2009. Expression of the Arf
tumor suppressor gene is controlled by Tgfbeta2 during development. Devel-
opment 136, 2081–2089.
Gil, J., Bernard, D., Martinez, D., Beach, D., 2004. Polycomb CBX7 has a unifying role
in cellular lifespan. Nat. Cell Biol. 6, 67–72.
Gil, J., Peters, G., 2006. Regulation of the INK4b-ARF-INK4a tumour suppressor
locus: all for one or one for all. Nat. Rev. Mol. Cell Biol. 7, 667–677.
Goldberg, M.F., 1997. Persistent fetal vasculature (PFV): an integrated interpretation
of signs and symptoms associated with persistent hyperplastic primary vitr-
eous (PHPV). LIV Edward Jackson Memorial Lecture. Am. J. Ophthalmol. 124,
587–626.
Hackett, S.F., Wiegand, S., Yancopoulos, G., Campochiaro, P.A., 2002. Angiopoietin-2
plays an important role in retinal angiogenesis. J. Cell. Physiol. 192, 182–187.
Haddad, R., Font, R.L., Reeser, F., 1978. Persistent hyperplastic primary vitreous.
A clinicopathologic study of 62 cases and review of the literature. Surv.
Ophthalmol. 23, 123–134.
Hannon, G.J., Beach, D., 1994. p15INK4B is a potential effector of TGF-beta-induced
cell cycle arrest. Nature 371, 257–261.
Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T.,
Jonasdottir, A., Sigurdsson, A., Baker, A., Palsson, A., Masson, G., Gudbjartsson,
D.F., Magnusson, K.P., Andersen, K., Levey, A.I., Backman, V.M., Matthiasdottir,
S., Jonsdottir, T., Palsson, S., Einarsdottir, H., Gunnarsdottir, S., Gylfason, A.,
Vaccarino, V., Hooper, W.C., Reilly, M.P., Granger, C.B., Austin, H., Rader, D.J.,
Shah, S.H., Quyyumi, A.A., Gulcher, J.R., Thorgeirsson, G., Thorsteinsdottir, U.,
Kong, A., Stefansson, K., 2007. A common variant on chromosome 9p21 affects
the risk of myocardial infarction. Science 316, 1491–1493.
Heyman, M., Einhorn, S., 1996. Inactivation of the p15INK4B and p16INK4 genes in
hematologic malignancies. Leuk. Lymphoma 23, 235–245.
Hirschi, K.K., D'Amore, P.A., 1996. Pericytes in the microvasculature. Cardiovasc. Res.
32, 687–698.
Hoch, R.V., Soriano, P., 2003. Roles of PDGF in animal development. Development
130, 4769–4784.
Jacobs, J.J., Kieboom, K., Marino, S., DePinho, R.A., van Lohuizen, M., 1999. The
oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and
senescence through the ink4a locus. Nature 397, 164–168.
Kamijo, T., Zindy, F., Roussel, M.F., Quelle, D.E., Downing, J.R., Ashmun, R.A.,
Grosveld, G., Sherr, C.J., 1997. Tumor suppression at the mouse INK4a locus
mediated by the alternative reading frame product p19ARF. Cell 91, 649–659.
Kato, M., Patel, M.S., Levasseur, R., Lobov, I., Chang, B.H., Glass 2nd, D.A., Hartmann,
C., Li, L., Hwang, T.H., Brayton, C.F., Lang, R.A., Karsenty, G., Chan, L., 2002. Cbfa1-
independent decrease in osteoblast proliferation, osteopenia, and persistent
embryonic eye vascularization in mice deﬁcient in Lrp5, a Wnt coreceptor.
J. Cell Biol. 157, 303–314.
Kotake, Y., Nakagawa, T., Kitagawa, K., Suzuki, S., Liu, N., Kitagawa, M., Xiong, Y.,
2011. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and
silencing of p15(INK4B) tumor suppressor gene. Oncogene 30, 1956–1962.
Krimpenfort, P., Quon, K.C., Mooi, W.J., Loonstra, A., Berns, A., 2001. Loss of p16Ink4a
confers susceptibility to metastatic melanoma in mice. Nature 413, 83–86.
Lang, R.A., Bishop, J.M., 1993. Macrophages are required for cell death and tissue
remodeling in the developing mouse eye. Cell 74, 453–462.
Latres, E., Malumbres, M., Sotillo, R., Martin, J., Ortega, S., Martin-Caballero, J., Flores,
J.M., Cordon-Cardo, C., Barbacid, M., 2000. Limited overlapping roles of P15
(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.
EMBO J. 19, 3496–3506.
Levine, A.J., 1989. The p53 tumor suppressor gene and gene product. Princess
Takamatsu Symp. 20, 221–230.
Levine, A.J., Momand, J., Finlay, C.A., 1991. The p53 tumour suppressor gene. Nature
351, 453–456.
Lin, A.W., Lowe, S.W., 2001. Oncogenic ras activates the ARF-p53 pathway to
suppress epithelial cell transformation. Proc. Natl. Acad. Sci. USA 98,
5025–5030.
Liu, Y., Sanoff, H.K., Cho, H., Burd, C.E., Torrice, C., Mohlke, K.L., Ibrahim, J.G., Thomas,
N.E., Sharpless, N.E., 2009. INK4/ARF transcript expression is associated with
chromosome 9p21 variants linked to atherosclerosis. PLoS One 4, e5027.
Lobov, I.B., Rao, S., Carroll, T.J., Vallance, J.E., Ito, M., Ondr, J.K., Kurup, S., Glass, D.A.,
Patel, M.S., Shu, W., Morrisey, E.E., McMahon, A.P., Karsenty, G., Lang, R.A., 2005.
WNT7b mediates macrophage-induced programmed cell death in patterning of
the vasculature. Nature 437, 417–421.
Martin, A.C., Thornton, J.D., Liu, J., Wang, X., Zuo, J., Jablonski, M.M., Chaum, E.,
Zindy, F., Skapek, S.X., 2004. Pathogenesis of persistent hyperplastic primary
vitreous in mice lacking the arf tumor suppressor gene. Invest. Ophthalmol.
Visual Sci. 45, 3387–3396.
McKeller, R.N., Fowler, J.L., Cunningham, J.J., Warner, N., Smeyne, R.J., Zindy, F.,
Skapek, S.X., 2002. The Arf tumor suppressor gene promotes hyaloid vascular
regression during mouse eye development. Proc. Natl. Acad. Sci. USA 99,
3848–3853.
McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D.R.,
Hinds, D.A., Pennacchio, L.A., Tybjaerg-Hansen, A., Folsom, A.R., Boerwinkle, E.,
Hobbs, H.H., Cohen, J.C., 2007. A common allele on chromosome 9 associated
with coronary heart disease. Science 316, 1488–1491.
Y. Zheng et al. / Developmental Biology 380 (2013) 49–57 57Palmero, I., Pantoja, C., Serrano, M., 1998. p19ARF links the tumour suppressor p53
to Ras. Nature 395, 125–126.
Pasmant, E., Laurendeau, I., Heron, D., Vidaud, M., Vidaud, D., Bieche, I., 2007.
Characterization of a germ-line deletion, including the entire INK4/ARF locus,
in a melanoma-neural system tumor family: identiﬁcation of ANRIL, an
antisense noncoding RNA whose expression coclusters with ARF. Cancer Res.
67, 3963–3969.
Quelle, D.E., Zindy, F., Ashmun, R.A., Sherr, C.J., 1995. Alternative reading frames of
the INK4a tumor suppressor gene encode two unrelated proteins capable of
inducing cell cycle arrest. Cell 83, 993–1000.
Reichel, M.B., Ali, R.R., D'Esposito, F., Clarke, A.R., Luthert, P.J., Bhattacharya, S.S.,
Hunt, D.M., 1998. High frequency of persistent hyperplastic primary vitreous
and cataracts in p53-deﬁcient mice. Cell Death Differ. 5, 156–162.
Rutland, C.S., Mitchell, C.A., Nasir, M., Konerding, M.A., Drexler, H.C., 2007.
Microphthalmia, persistent hyperplastic hyaloid vasculature and lens anoma-
lies following overexpression of VEGF-A188 from the alphaA-crystallin promo-
ter. Mol. Vision 13, 47–56.
Saxena, R., Voight, B.F., Lyssenko, V., Burtt, N.P., de Bakker, P.I., Chen, H., Roix, J.J.,
Kathiresan, S., Hirschhorn, J.N., Daly, M.J., Hughes, T.E., Groop, L., Altshuler, D.,
Almgren, P., Florez, J.C., Meyer, J., Ardlie, K., Bengtsson Bostrom, K., Isomaa, B.,
Lettre, G., Lindblad, U., Lyon, H.N., Melander, O., Newton-Cheh, C., Nilsson, P.,
Orho-Melander, M., Rastam, L., Speliotes, E.K., Taskinen, M.R., Tuomi, T.,
Guiducci, C., Berglund, A., Carlson, J., Gianniny, L., Hackett, R., Hall, L.,
Holmkvist, J., Laurila, E., Sjogren, M., Sterner, M., Surti, A., Svensson, M.,
Tewhey, R., Blumenstiel, B., Parkin, M., Defelice, M., Barry, R., Brodeur, W.,
Camarata, J., Chia, N., Fava, M., Gibbons, J., Handsaker, B., Healy, C., Nguyen, K.,
Gates, C., Sougnez, C., Gage, D., Nizzari, M., Gabriel, S.B., Chirn, G.W., Ma, Q.,
Parikh, H., Richardson, D., Ricke, D., Purcell, S, 2007. Genome-wide association
analysis identiﬁes loci for type 2 diabetes and triglyceride levels. Science 316,
1331–1336.
Scott, L.J., Mohlke, K.L., Bonnycastle, L.L., Willer, C.J., Li, Y., Duren, W.L., Erdos, M.R.,
Stringham, H.M., Chines, P.S., Jackson, A.U., Prokunina-Olsson, L., Ding, C.J.,
Swift, A.J., Narisu, N., Hu, T., Pruim, R., Xiao, R., Li, X.Y., Conneely, K.N., Riebow,
N.L., Sprau, A.G., Tong, M., White, P.P., Hetrick, K.N., Barnhart, M.W., Bark, C.W.,
Goldstein, J.L., Watkins, L., Xiang, F., Saramies, J., Buchanan, T.A., Watanabe, R.
M., Valle, T.T., Kinnunen, L., Abecasis, G.R., Pugh, E.W., Doheny, K.F., Bergman, R.
N., Tuomilehto, J., Collins, F.S., Boehnke, M., 2007. A genome-wide association
study of type 2 diabetes in Finns detects multiple susceptibility variants.
Science 316, 1341–1345.
Serrano, M., Hannon, G.J., Beach, D., 1993. A new regulatory motif in cell-cycle
control causing speciﬁc inhibition of cyclin D/CDK4. Nature 366, 704–707.
Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D., DePinho, R.A., 1996. Role of
the INK4a locus in tumor suppression and cell mortality. Cell 85, 27–37.
Sharpless, N.E., Bardeesy, N., Lee, K.H., Carrasco, D., Castrillon, D.H., Aguirre, A.J.,
Wu, E.A., Horner, J.W., DePinho, R.A., 2001. Loss of p16Ink4a with retention of
p19Arf predisposes mice to tumorigenesis. Nature 413, 86–91.Sharpless, N.E., DePinho, R.A., 1999. The INK4A/ARF locus and its two gene
products. Curr. Opin. Genet. Dev. 9, 22–30.
Shastry, B.S., 2009. Persistent hyperplastic primary vitreous: congenital malforma-
tion of the eye. Clin. Exp. Ophthalmol. 37, 884–890.
Sherr, C.J., DePinho, R.A., 2000. Cellular senescence: mitotic clock or culture shock?
Cell 102, 407–410.
Silva, R.L., Thornton, J.D., Martin, A.C., Rehg, J.E., Bertwistle, D., Zindy, F., Skapek, S.
X., 2005. Arf-dependent regulation of Pdgf signaling in perivascular cells in the
developing mouse eye. EMBO J. 24, 2803–2814.
de Stanchina, E., McCurrach, M.E., Zindy, F., Shieh, S.Y., Ferbeyre, G., Samuelson, A.V.,
Prives, C., Roussel, M.F., Sherr, C.J., Lowe, S.W., 1998. E1A signaling to p53 involves
the p19(ARF) tumor suppressor. Genes Dev. 12, 2434–2442.
Taharaguchi, S., Yoshida, K., Tomioka, Y., Yoshino, S., Uede, T., Ono, E., 2005.
Persistent hyperplastic primary vitreous in transgenic mice expressing IE180
of the pseudorabies virus. Invest. Ophthalmol. Visual Sci. 46, 1551–1556.
Thornton, J.D., Swanson, D.J., Mary, M.N., Pei, D., Martin, A.C., Pounds, S., Goldowitz,
D., Skapek, S.X., 2007. Persistent hyperplastic primary vitreous due to somatic
mosaic deletion of the arf tumor suppressor. Invest. Ophthalmol. Visual Sci. 48,
491–499.
Visel, A., Zhu, Y., May, D., Afzal, V., Gong, E., Attanasio, C., Blow, M.J., Cohen, J.C.,
Rubin, E.M., Pennacchio, L.A., 2010. Targeted deletion of the 9p21 non-coding
coronary artery disease risk interval in mice. Nature 464, 409–412.
Widau, R.C., Zheng, Y., Sung, C.Y., Zelivianskaia, A., Roach, L.E., Bachmeyer, K.M.,
Abramova, T., Desgardin, A., Rosner, A., Cunningham, J.M., Skapek, S.X., 2012.
p19Arf represses platelet-derived growth factor receptor beta by transcriptional
and posttranscriptional mechanisms. Mol. Cell. Biol. 32, 4270–4282.
Yap, K.L., Li, S., Munoz-Cabello, A.M., Raguz, S., Zeng, L., Mujtaba, S., Gil, J., Walsh, M.
J., Zhou, M.M., 2010. Molecular interplay of the noncoding RNA ANRIL and
methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing
of INK4a. Mol. Cell 38, 662–674.
Zeggini, E., Weedon, M.N., Lindgren, C.M., Frayling, T.M., Elliott, K.S., Lango, H.,
Timpson, N.J., Perry, J.R., Rayner, N.W., Freathy, R.M., Barrett, J.C., Shields, B.,
Morris, A.P., Ellard, S., Groves, C.J., Harries, L.W., Marchini, J.L., Owen, K.R.,
Knight, B., Cardon, L.R., Walker, M., Hitman, G.A., Morris, A.D., Doney, A.S.,
McCarthy, M.I., Hattersley, A.T., 2007. Replication of genome-wide association
signals in UK samples reveals risk loci for type 2 diabetes. Science 316,
1336–1341.
Zheng, Y., Zhao, Y.D., Gibbons, M., Abramova, T., Chu, P.Y., Ash, J.D., Cunningham, J.
M., Skapek, S.X., 2010. Tgfbeta signaling directly induces Arf promoter remo-
deling by a mechanism involving Smads 2/3 and p38 MAPK. J. Biol. Chem. 285,
35654–35664.
Zindy, F., Eischen, C.M., Randle, D.H., Kamijo, T., Cleveland, J.L., Sherr, C.J., Roussel,
M.F., 1998. Myc signaling via the ARF tumor suppressor regulates p53-
dependent apoptosis and immortalization. Genes Dev. 12, 2424–2433.
Zindy, F., Quelle, D.E., Roussel, M.F., Sherr, C.J., 1997. Expression of the p16INK4a
tumor suppressor versus other INK4 family members during mouse develop-
ment and aging. Oncogene 15, 203–211.
